CA1306208C - Augmentation de l'expression et de la stabilisation des produits genetiquesdans les microorganismes a l'aide de courtes sequences-signaux choisies - Google Patents
Augmentation de l'expression et de la stabilisation des produits genetiquesdans les microorganismes a l'aide de courtes sequences-signaux choisiesInfo
- Publication number
- CA1306208C CA1306208C CA 471799 CA471799A CA1306208C CA 1306208 C CA1306208 C CA 1306208C CA 471799 CA471799 CA 471799 CA 471799 A CA471799 A CA 471799A CA 1306208 C CA1306208 C CA 1306208C
- Authority
- CA
- Canada
- Prior art keywords
- sequence
- polypeptide
- dna sequence
- codes
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Endocrinology (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 471799 CA1306208C (fr) | 1985-01-09 | 1985-01-09 | Augmentation de l'expression et de la stabilisation des produits genetiquesdans les microorganismes a l'aide de courtes sequences-signaux choisies |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 471799 CA1306208C (fr) | 1985-01-09 | 1985-01-09 | Augmentation de l'expression et de la stabilisation des produits genetiquesdans les microorganismes a l'aide de courtes sequences-signaux choisies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1306208C true CA1306208C (fr) | 1992-08-11 |
Family
ID=4129550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 471799 Expired - Lifetime CA1306208C (fr) | 1985-01-09 | 1985-01-09 | Augmentation de l'expression et de la stabilisation des produits genetiquesdans les microorganismes a l'aide de courtes sequences-signaux choisies |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA1306208C (fr) |
-
1985
- 1985-01-09 CA CA 471799 patent/CA1306208C/fr not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5359035A (en) | Bifunctional proteins including interleukin-2 (IL-2) and granuloctyte macrophage colony stimulating factor (GM-CSF) | |
| US5143844A (en) | Construction of an igg binding protein to facilitate downstream processing using protein engineering | |
| US5004686A (en) | Process for producing human epidermal growth factor and analogs thereof | |
| Park et al. | Design, synthesis, and functional expression of a gene for charybdotoxin, a peptide blocker of K+ channels. | |
| DE3586750T2 (de) | Rekombinante fusionsproteine. | |
| EP0043980B1 (fr) | Interferon A mature de leucocytes humains, procédé pour sa production microbienne, produits intermédiaires correspondents et compositions le contenants | |
| CA1341203C (fr) | Proteines de fusion eucaryotiques contenant des sequences d'interleukin-2 | |
| AU613022B2 (en) | Bifunctional proteins | |
| CA2006578A1 (fr) | Analogues de l'insuline humaine | |
| US4832959A (en) | Preparation of polypeptides having human γ-interferon activity | |
| CA1339894C (fr) | Proteines hybrides a ballast eukaryotique | |
| US5026639A (en) | Method to improve mRNA translation and use thereof for production of platelet factor-4 | |
| US5334532A (en) | PDGF-B fusion protein, vectors, and host cells for use in production thereof | |
| HU196846B (en) | Process for producing biologically active derivatives of human gamma-interferon and pharmaceutical compositions comprising the same | |
| AU617999B2 (en) | A genetic engineering process for the preparation of angiogenins | |
| US4828988A (en) | Hybrid polypeptides comprising somatocrinine and alpha1 -antitrypsin, method for their production from bacterial clones and use thereof for the production of somatocrinine | |
| US5187075A (en) | Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses | |
| Chang et al. | Initiation of protein synthesis in bacteria at a translational start codon of mamalian cDNA: effects of the preceding nucleotide sequence. | |
| CA2016018A1 (fr) | Purification de proteines par des fusions ctap-iii | |
| JPH0195791A (ja) | 新規なポリペプチド、その製法、そのためのベクター及びそれを含有する医薬 | |
| Janoueix-Lerosey et al. | Regulation of the GTPase activity of the ras-related rap2 protein | |
| WO1988005787A1 (fr) | Facteur beta de croissance de transformation | |
| US5459049A (en) | Motilin-like polypeptide and use thereof | |
| DE3900770A1 (de) | Verfahren zur herstellung von pdgf-a und pdgf-aa | |
| EP0353516B1 (fr) | Méthode de préparation de la bêta-interleukine-1 humaine recombinante en forme homogène |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKLA | Lapsed |